Heart rate variability and clinical cardiology.

od Amadi, A, Coats, A J
Izdano 1994

Visual field defects associated with vigabatrin monotherapy in children

od LUCHETTI, A., AMADI, A., GOBBI, G., BERTANI, G.
Izdano 2000

Beta adrenoceptor density in the donor heart: a guide to prognosis?

od Chester, M. R., Amadi, A. A., Barnett, D. B.
Izdano 1995

Lacrimal Gland Changes on Orbital Imaging after Glaucoma Drainage Implant Surgery

od Jacobs, Sarah M., Mudumbai, Raghu C., Amadi, A.J.
izdano v J Ophthalmic Vis Res (2018)

From trench fever to endocarditis

od Mann, P, Nye, F, Williams, G, Walker, A, Amadi, A
Izdano 2003

ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease.

od Henein, M. Y., Amadi, A., O'Sullivan, C., Coats, A., Gibson, D. G.
Izdano 1996

Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure.

od Stevenson, R N, Keywood, C, Amadi, A A, Davies, J R, Patterson, D L
Izdano 1991

Ocular injuries from fireworks: the 11-year experience of a US level I trauma center

od Chang, I T, Prendes, M A, Tarbet, K J, Amadi, A J, Chang, S-H, Shaftel, S S
izdano v Eye (Lond) (2016)

Blood Glucose Control and Medication Adherence Among Adult Type 2 Diabetic Nigerians Attending A Primary Care Clinic in Under-resourced Environment of Eastern Nigeria

od Pascal, Iloh GU, Ofoedu, John N, Uchenna, Njoku P, Nkwa, Amadi A, Uchamma, Godswill-Uko E
Izdano 2012

Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.

od McHugh, N J, Csuka, M, Watson, H, Belcher, G, Amadi, A, Ring, E F, Black, C M, Maddison, P J
Izdano 1988

Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of...

od Lee, D., Amadi, A., Sabater, J., Ellis, J., Johnson, H., Kotapati, S., McNamara, S., Walker, A., Cooper, M., Patterson, K., Roskell, N., Meng, Y.
izdano v Pharmacoecon Open (2018)

Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with...

od Lee, D., Amadi, A., Sabater, J., Ellis, J., Johnson, H., Kotapati, S., McNamara, S., Walker, A., Cooper, M., Patterson, K., Roskell, N., Meng, Y.
izdano v Pharmacoecon Open (2018)